Free Newsletter
SPOTLIGHT: Recall cuts Medtronic profits, but not much
Free newsletter via e-mail
Tools
Medtronic's quarterly earnings weren't hit as hard as expected by the recall of its Fidelis defibrillator lead; the device maker posted $666 million in earnings on $3.12 billion in revenues. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: